Maynard Um
-
-
-
-
-
-
-
Cosmos Health antiseptic product nears $1.3M in annualized sales in Greece
-
-
-
-
-
-
-
Cosmos Health secures 5-year CERTORUN manufacturing deal worth 385,000 units
-
-
-
-
-
-
-
Cosmos Health issues 2026-2029 guidance targeting $200m revenue by 2029
-
-
-
-
-
-
-
Cosmos Health withdraws SEC registration statement for public offering
-
-
-
-
-
-
-
Cosmos Health projects $2.5 million revenue from Cur18 supplement
-
-
-
-
-
-
-
Cosmos Health deploys AI across operations, targets 30% cost reduction
-
-
-
-
-
-
-
Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months
-
424,862 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

